Long COVID is now a term recognized worldwide. We talked with Ani Nalbandian, MD, lead author of the most comprehensive review-to-date, about what she and her colleagues have learned.
A new study on conversion of acute to chronic low back pain identifies clinician behavior as well as patient characteristics that increase that risk.
ENDO 2021: Fewer than 1-in-10 older adults with a hip fracture had been prescribed bone-directed treatment in the 6 months prior to the incident, according to research on trends in treatment.
Study: Anosmia, myalgias, and headache were the most common extrapulmonary symptoms seen in COVID-19 patients at first presentation, say investigators.
Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.
A recent meta-analysis assessed comparative clinical efficacy of NSAIDs and COX-2 inhibitors. Try these 7 questions on the findings - does your clinical experience match?
Cannabis researchers Drs Carrie Cuttler and Rebecca Craft discuss their findings, their labs at WSU, their new research, and what makes this kind of research a challenge.
Pain is a common complication of COVID-19 infection, during the illness and afterwards. Click through this summary of new data on acute pain and risk for persistent pain from COVID-19.
Authors of 2 large cannabis-user database analyses discuss the possible reasons for observed dose increase over time by individuals using inhaled cannabis for pain relief.
In animal models, pain relief from cannabis has been found to be greater in females; new research on pain relief from inhaled cannabis in regular users found something different.